Role of CCL7 in Type I hypersensitivity reactions in murine experimental allergic conjunctivitis

Journal of Immunology

Volumn 198, Issue 2, 2017, Pages 645-656

  Kuo, Chuan Hui ^a   Collins, Andrea M ^a   Boettner, Douglas R ^a   Yang, Yanfen ^a   Ono, Santa J ^a,b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; MONOCYTE CHEMOTACTIC PROTEIN 3; OVALBUMIN; CCL7 PROTEIN, MOUSE;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY MEDIATED REJECTION; ARTICLE; BONE MARROW DERIVED MAST CELL; CALCIUM TRANSPORT; CELL ACTIVITY; CELL FUNCTION; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; IN VITRO STUDY; IN VIVO STUDY; MAST CELL DEGRANULATION; MOUSE; MURINE MODEL; NONHUMAN; PROTEIN FUNCTION; UPREGULATION; WILD TYPE; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; DEGRANULATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; MAST CELL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEGRANULATION; CHEMOKINE CCL7; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 85014609352     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502416     Document Type: Article

References (64)

1. Saban, D. R., V. Calder, C. H. Kuo, N. J. Reyes, D. A. Dartt, S. J. Ono, and J. Y. Niederkorn. 2013. New twists to an old story: novel concepts in the pathogenesis of allergic eye disease. Curr. Eye Res. 38: 317-330
2. O'Brien, T. P. 2013. Allergic conjunctivitis: an update on diagnosis and management. Curr. Opin. Allergy Clin. Immunol. 13: 543-549
3. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mastcell activation. Nat. Rev. Immunol. 6: 218-230
4. Galli, S. J., and M. Tsai. 2008. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J. Dermatol. Sci. 49: 7-19
5. Toda, M., T. Nakamura, M. Ohbayashi, Y. Ikeda, M. Dawson, C. C. Aye, D. Miyazaki, and S. J. Ono. 2007. Mechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors. Expert Rev. Clin. Immunol. 3: 351-364
6. Toda, M., and S. J. Ono. 2002. Genomics and proteomics of allergic disease. Immunology 106: 1-10
7. Miyazaki, D., T. Nakamura, M. Toda, K. W. Cheung-Chau, R. M. Richardson, and S. J. Ono. 2005.Macrophage inflammatory protein-1a as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J. Clin. Invest. 115: 434-442
8. Toda, M., M. Dawson, T. Nakamura, P. M. Munro, R. M. Richardson, M. Bailly, and S. J. Ono. 2004. Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility. J. Biol. Chem. 279: 48443-48448
9. Romagnani, P., A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, S. Romagnani, and G. Marone. 1999. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am. J. Pathol. 155: 1195-1204
10. Ochi, H.,W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190: 267-280
11. Quackenbush, E. J., B. K. Wershil, V. Aguirre, and J. C. Gutierrez-Ramos. 1998. Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors. Blood 92: 1887-1897
12. Miyazaki, D., T. Nakamura, M. Ohbayashi, C. H. Kuo, N. Komatsu, K. Yakura, T. Tominaga, Y. Inoue, H. Higashi, M. Murata, et al. 2009. Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade. Int. Immunol. 21: 187-201
13. Fukuda, K., C. H. Kuo, K. Morohoshi, F. T. Liu, and S. J. Ono. 2012. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgEmediated allergic conjunctivitis. Br. J. Ophthalmol. 96: 1132-1136
14. Nakamura, T., M. Ohbayashi, M. Toda, D. A. Hall, C. M. Horgan, and S. J. Ono. 2005. A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva. Immunol. Res. 33: 213-221
15. Komatsu, N., D. Miyazaki, T. Tominaga, C. H. Kuo, S. Namba, S. Takeda, H. Higashi, and Y. Inoue. 2008. Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 49: 5307-5313
16. Alam, R., P. A. Forsythe, S. Stafford, M. A. Lett-Brown, and J. A. Grant. 1992. Macrophage inflammatory protein-1 a activates basophils and mast cells. J. Exp. Med. 176: 781-786
17. Fifadara, N. H., C. C. Aye, S. K. Raghuwanshi, R. M. Richardson, and S. J. Ono. 2009. CCR1 expression and signal transduction by murine BMMC results in secretion of TNF-a, TGFbeta-1 and IL-6. Int. Immunol. 21: 991-1001
18. Liehn, E. A., M. W. Merx, O. Postea, S. Becher, Y. D. Talab, E. Shagdarsuren, M. Kelm, A. Zernecke, and C. Weber. 2007. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction. J. Cell. Mol. Med 12: 496-506
19. Amat, M., C. F. Benjamim, L. M. Williams, N. Prats, E. Terricabras, J. Beleta, S. L. Kunkel, and N. Godessart. 2006. Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo. Br. J. Pharmacol. 149: 666-675
20. Chou, R. C., N. D. Kim, C. D. Sadik, E. Seung, Y. Lan, M. H. Byrne, B. Haribabu, Y. Iwakura, and A. D. Luster. 2010. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33: 266-278
21. Carpenter, K. J., J. L. Ewing, J. M. Schuh, T. L. Ness, S. L. Kunkel, M. Aparici, M. Miralpeix, and C. M. Hogaboam. 2005. Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice. Br. J. Pharmacol. 145: 1160-1172
22. Toda, M., C. H. Kuo, S. K. Borman, R. M. Richardson, A. Inoko, M. Inagaki, A. Collins, K. Schneider, and S. J. Ono. 2012. Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcRI/CC chemokine receptor 1 cross-talk. J. Biol. Chem. 287: 24516-24524
23. Aye, C. C., M. Toda, K. Morohoshi, and S. J. Ono. 2012. Identification of genes and proteins specifically regulated by costimulation of mast cell Fc receptor I and chemokine receptor 1. Exp. Mol. Pathol. 92: 267-274
24. Jacobsson, B., R. M. Holst, B. Andersson, and H. Hagberg. 2005. Monocyte chemotactic protein-2 and-3 in amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation and preterm delivery. Acta Obstet. Gynecol. Scand. 84: 566-571
25. Schenk, S., N. Mal, A. Finan, M. Zhang, M. Kiedrowski, Z. Popovic, P. M. McCarthy, and M. S. Penn. 2007. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25: 245-251
26. Wakahara, S., Y. Fujii, T. Nakao, K. Tsuritani, T. Hara, H. Saito, and C. Ra. 2001. Gene expression profiles for Fc RI, cytokines and chemokines upon Fc RI activation in human cultured mast cells derived from peripheral blood. Cytokine 16: 143-152
27. Maddaluno, M., M. Di Lauro, A. Di Pascale, R. Santamaria, A. Guglielmotti, G. Grassia, and A. Ialenti. 2011. Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis 217: 113-119
28. Dahinden, C. A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 179: 751-756
29. Xu, L. L., D.W. McVicar, A. Ben-Baruch, D. B. Kuhns, J. Johnston, J. J. Oppenheim, and J. M. Wang. 1995. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur. J. Immunol. 25: 2612-2617
30. Fujisawa, T., Y. Kato, H. Nagase, J. Atsuta, A. Terada, K. Iguchi, H. Kamiya, Y. Morita, M. Kitaura, H. Kawasaki, et al. 2000. Chemokines induce eosinophil degranulation through CCR-3. J. Allergy Clin. Immunol. 106: 507-513
31. Batra, J., S. Das, R. Chatterjee, S. Chandra, and B. Ghosh. 2011. Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population. J. Allergy Clin. Immunol. 128: 239-242.e233
32. Rojas-Ramos, E., A. F. Avalos, L. Pé rez-Fernandez, F. Cuevas-Schacht, E. Valencia-Maqueda, and L. M. Terán. 2003. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and-4, and eotaxins-1 and-2 in childhood asthma. Eur. Respir. J. 22: 310-316
33. Michalec, L., B. K. Choudhury, E. Postlethwait, J. S. Wild, R. Alam, M. Lett-Brown, and S. Sur. 2002. CCL7 and CXCL10 orchestrate oxidative stressinduced neutrophilic lung inflammation. J. Immunol. 168: 846-852
34. Kupczyk, M., Z. Kurmanowska, I. Kuprys-Lipinska, M. Bochenska-Marciniak, and P. Kuna. 2010. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir. Med. 104: 1404-1409
35. Christodoulopoulos, P., E. Wright, S. Frenkiel, A. Luster, and Q. Hamid. 1999. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J. Allergy Clin. Immunol. 103: 1036-1044
36. Ichinose, T., S. Yoshida, K. Sadakane, H. Takano, R. Yanagisawa, K. Inoue, M. Nishikawa, I. Mori, H. Kawazato, A. Yasuda, and T. Shibamoto. 2008. Effects of Asian sand dust, Arizona sand dust, amorphous silica and aluminum oxide on allergic inflammation in the murine lung. Inhal. Toxicol. 20: 685-694
37. Stafford, S., H. Li, P. A. Forsythe, M. Ryan, R. Bravo, and R. Alam. 1997. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J. Immunol. 158: 4953-4960
38. Richardson, R. M., B. C. Pridgen, B. Haribabu, and R. Snyderman. 2000. Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2. J. Biol. Chem. 275: 9201-9208
39. Groschwitz, K. R., R. Ahrens, H. Osterfeld, M. F. Gurish, X. Han, M. Abrink, F. D. Finkelman, G. Pejler, and S. P. Hogan. 2009. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc. Natl. Acad. Sci. USA 106: 22381-22386
40. Yamada, N., H. Matsushima, Y. Tagaya, S. Shimada, and S. I. Katz. 2003. Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J. Invest. Dermatol. 121: 1425-1432
41. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45
42. Ishida, W., E. Tsuru, A. Tominaga, J. I. Miyazaki, T. Higuchi, S. Sakamoto, and A. Fukushima. 2009. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis. Br. J. Ophthalmol. 93: 1680-1685
43. Oliveira, S. H., and N. W. Lukacs. 2001. Stem cell factor and IgE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm. Res. 50: 168-174
44. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509-514
45. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709
46. Artemenko, Y., T. J. Lampert, and P. N. Devreotes. 2014. Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytes. Cell. Mol. Life Sci. 71: 3711-3747
47. Takayama, G., M. Ohtani, A. Minowa, S. Matsuda, and S. Koyasu. 2013. Class I PI3K-mediated Akt and ERK signals play a critical role in FcRI-induced degranulation in mast cells. Int. Immunol. 25: 215-220
48. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192: 729-740
49. Welle, M. 1997. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61: 233-245
50. Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. 2005. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175: 2635-2642
51. Hartmann, K., F. Beiglböck, B. M. Czarnetzki, and T. Zuberbier. 1995. Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int. Arch. Allergy Immunol. 108: 224-230
52. Hartmann, K., B. M. Henz, S. Krüger-Krasagakes, J. Köhl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier. 1997. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89: 2863-2870
53. Alam, R., P. Forsythe, S. Stafford, J. Heinrich, R. Bravo, P. Proost, and J. Van Damme. 1994. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J. Immunol. 153: 3155-3159
54. Forsythe, P., and M. Ennis. 2000. Clinical consequences of mast cell heterogeneity. Inflamm. Res. 49: 147-154
55. Fukuda, K., M. Ohbayashi, K. Morohoshi, L. Zhang, F. T. Liu, and S. J. Ono. 2009. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis. J. Allergy Clin. Immunol. 124: 827-833.e2
56. Zouggari, Y., H. Ait-Oufella, P. Bonnin, T. Simon, A. P. Sage, C. Guérin, J. Vilar, G. Caligiuri, D. Tsiantoulas, L. Laurans, et al. 2013. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19: 1273-1280
57. Katzman, S. D., and D. J. Fowell. 2008. Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. J. Clin. Invest. 118: 801-811
58. Fiorina, P., M. Jurewicz, A. Vergani, A. Augello, J. Paez, V. Ricchiuti, V. Tchipachvili, M. H. Sayegh, and R. Abdi. 2008. Phenotypic and functional differences between wild-type and CCR2-/-dendritic cells: implications for islet transplantation. Transplantation 85: 1030-1038
59. Geha, R. S., H. H. Jabara, and S. R. Brodeur. 2003. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3: 721-732
60. Potaczek, D. P., and M. Kabesch. 2012. Current concepts of IgE regulation and impact of genetic determinants. Clin. Exp. Allergy 42: 852-871
61. Borish, L. C., and J. W. Steinke. 2003. 2. Cytokines and chemokines. J. Allergy Clin. Immunol. 111(2 Suppl.): S460-S475
62. Schall, T. J., K. Bacon, R. D. Camp, J.W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177: 1821-1826
63. Kuna, P., S. R. Reddigari, T. J. Schall, D. Rucinski, M. Sadick, and A. P. Kaplan. 1993. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J. Immunol. 150: 1932-1943
64. Collington, S. J., J. Hallgren, J. E. Pease, T. G. Jones, B. J. Rollins, J. Westwick, K. F. Austen, T. J.Williams, M. F. Gurish, and C. L.Weller. 2010. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J. Immunol. 184: 6114-6123.